$982.29
14.31[1.48%]
At close: May 17
$982.29
0[0.00%]
After Hours: 4:00PM EDT
Regeneron Pharmaceuticals
(NASDAQ:REGN)Regeneron Pharmaceuticals Stock (NASDAQ:REGN), Earnings Estimates, EPS, and Revenue
Regeneron Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS
$9.550
Quarterly Revenue
$3.1B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$13.1B
Analyze the earnings history of Regeneron Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | $10.24 | — | — | — | $3.16B | — | — | — | 08/01/2024 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $10.09 | $10.10 | $9.55 | -5.45% | $3.16B | $3.22B | $3.15B | -2.33% | 05/02/2024 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $12.56 | $10.77 | $11.86 | 10.12% | $3.41B | $3.29B | $3.43B | 4.38% | 02/02/2024 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $11.14 | $10.77 | $11.59 | 7.61% | $2.94B | $3.22B | $3.36B | 4.44% | 11/02/2023 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $9.77 | $9.92 | $10.24 | 3.23% | $2.86B | $3.01B | $3.16B | 4.92% | 08/03/2023 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $11.49 | $9.60 | $10.09 | 5.10% | $2.96B | $3.00B | $3.16B | 5.40% | 05/04/2023 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $23.42 | $10.03 | $12.56 | 25.22% | $4.95B | $3.13B | $3.41B | 9.07% | 02/03/2023 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $15.37 | $9.52 | $11.14 | 17.02% | $3.45B | $2.88B | $2.94B | 1.94% | 11/03/2022 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $25.80 | $9.54 | $9.77 | 2.41% | $5.14B | $2.79B | $2.86B | 2.40% | 08/03/2022 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $9.89 | $10.04 | $11.49 | 14.44% | $2.53B | $2.73B | $2.96B | 8.61% | 05/04/2022 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $9.53 | $18.11 | $23.72 | 30.98% | $2.42B | $4.47B | $4.95B | 10.78% | 02/04/2022 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $8.36 | $9.49 | $15.37 | 61.96% | $2.29B | $2.79B | $3.45B | 23.76% | 11/04/2021 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $7.16 | $17.69 | $25.80 | 45.85% | $1.95B | $3.89B | $5.14B | 32.11% | 08/05/2021 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $6.60 | $9.03 | $9.89 | 9.52% | $1.83B | $2.56B | $2.53B | -1.21% | 05/06/2021 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $7.50 | $8.39 | $9.53 | 13.59% | $2.17B | $2.42B | $2.42B | 0.12% | 02/05/2021 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $6.67 | $7.09 | $8.36 | 17.91% | $2.05B | $2.09B | $2.29B | 9.76% | 11/05/2020 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $6.04 | $5.98 | $7.16 | 19.73% | $1.93B | $1.74B | $1.95B | 12.18% | 08/05/2020 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $4.45 | $6.20 | $6.60 | 6.45% | $1.71B | $1.85B | $1.83B | -1.19% | 05/05/2020 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $6.84 | $6.90 | $7.50 | 8.70% | $1.93B | $2.11B | $2.17B | 2.84% | 02/06/2020 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $5.87 | — | $6.67 | — | $1.66B | — | $2.05B | — | 11/05/2019 | Get Alert |
| REGN | Regeneron Pharmaceuticals | $5.45 | $5.37 | $6.04 | 12.48% | $1.61B | $1.80B | $1.93B | 7.44% | 08/06/2019 | Get Alert |
FAQ
When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?
Regeneron Pharmaceuticals (REGN) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Regeneron Pharmaceuticals (NASDAQ:REGN)?
The Actual EPS was $9.55, which missed the estimate of $10.10.
What were Regeneron Pharmaceuticals’s (NASDAQ:REGN) revenues?
The Actual Revenue was $3.1B, which missed the estimate of $3.2B.
Browse earnings estimates, EPS, and revenue on all stocks.